Ampersand Capital Partners, a private equity firm, has invested in Syft Technologies, a provider of mass spectrometry services.
Syft’s instruments enable the analysis of compounds in air and are used in industries including energy and life sciences. The company is a developer and provider of Selected Ion Flow Tube Mass Spectrometry (SIFT-MS) services. Ampersand is a middle-market private equity firm with more than $2 billion of assets under management dedicated to growth-oriented investments in the healthcare sector.
Alex Fala, CEO of Syft, comments “We are excited to partner with Ampersand and benefit from the firm’s expertise and networks as we continue to build on Syft’s momentum and develop our next scalable opportunity in life sciences.”